CEACAM5 and colon adenocarcinoma: In conclusion, these data highlight the potential of CEA and CA 125, and we suggest that CEA may be a useful tool for predicting the recurrence of colon adenocarcinoma and estimating disease-free survival durations in patients who have undergone surgery.